Feeds:
Posts
Comments

Search Results for 'CABG'

UPDATED on 12/26/2020 – CABG: a Superior Revascularization Modality to PCI in Patients with poor LVF, Multivessel disease and Diabetes, Similar Risk of Stroke between 31 days and 5 years, post intervention Reporter: Aviva Lev-Ari, PhD, RN   UPDATED on 12/26/2020 Five-Year Outcomes after PCI or CABG for Left Main Coronary Disease List of authors. […]

Read Full Post »

PCI, CABG, CHF, AMI – Two Payment Methods: Bundled payments (hospitalization costs, up to 90 days of post-acute care, nursing home care, complications, and rehospitalizations) vs Diagnosis-related groupings cover only what happens in the hospital. Reporter: Aviva Lev-Ari, PhD, RN   UPDATED on 8/17/2018 Certain risk factors make survivors of an acute MI more likely […]

Read Full Post »

Curations on MedTech (Cardiac Imaging) and Cardiac and Cardiovascular Medical Devices in use for Cardiac Surgery, Cardiothoracic Surgical Procedures and Percutaneous Coronary Intervention (PCI) / Coronary Angioplasty   Single-Author Curations by Aviva Lev-Ari, PhD, RN On 8/13/2018 Curations, N = 41   42c    Experimental Therapy (Left inter-atrial shunt implant device) for Heart Failure: Expert Opinion on […]

Read Full Post »

Cardiac Surgery Recommendations Switch to Patient Blood Management — Four societies outline pre- to post-op strategies to improve outcomes by Crystal Phend, Contributing Editor, MedPage Today June 30, 2021 Reporter: Aviva Lev-Ari, PhD, RN STS/SCA/AmSECT/SABM Update to the Clinical Practice Guidelines on Patient Blood Management Pierre Tibi, MD R. Scott McClure, MD, FRCSC Jiapeng Huang, MD Scott […]

Read Full Post »

UPDATED on 2/25/2019 https://www.medpagetoday.com/cardiology/prevention/78202?xid=nl_mpt_SRCardiology_2019-02-25&eun=g99985d0r&utm_source=Sailthru&utm_medium=email&utm_campaign=CardioUpdate_022519&utm_term=NL_Spec_Cardiology_Update_Active The FDA approved the first ultrathin strut drug-eluting stent, Orsiro, as well as a shelf-stable, premixed vancomycin injection for infective endocarditis and other indications. UPDATED on 3/16/2019 https://www.medpagetoday.com/cardiology/prevention/78202?xid=nl_mpt_SRCardiology_2019-02-25&eun=g99985d0r&utm_source=Sailthru&utm_medium=email&utm_campaign=CardioUpdate_022519&utm_term=NL_Spec_Cardiology_Update_Active Dual antiplatelet therapy with ticagrelor (Brilinta) reduced major adverse cardiovascular events in type 2 diabetes patients with coronary artery disease but no prior heart attack or […]

Read Full Post »

Left Main Coronary Artery Disease (LMCAD): Stents vs CABG – The less-invasive option is Equally Safe and Effective Reporter: Aviva Lev-Ari, PhD, RN Original Article in NEJM http://www.nejm.org/doi/pdf/10.1056/NEJMoa1610227 Based on Stents, Bypass Surgery Equally Safe and Effective for Many with Left Main Heart Disease – Stents offer less-invasive option for many patients with left main […]

Read Full Post »

2017 American Heart Association Annual Meeting: Sunday’s Science at #AHA17 – Presidential Address Reporter: Aviva Lev-Ari, PhD, RN   WATCH VIDEOS http://professional.heart.org/professional/EducationMeetings/MeetingsLiveCME/ScientificSessions/UCM_316934_Science-News-Scientific-Sessions.jsp#vid-ss17-open1   Best of Sunday at Scientific Sessions 2017 • TRiCS III – What differences were seen in cardiac surgery outcomes with restrictive red cell transfusion vs a more liberal strategy? • DACAB – […]

Read Full Post »

Risks from Dual Antiplatelet Therapy (DAPT) may be reduced by Genotyping Guidance of Cardiac Patients Reporter: Aviva Lev-Ari, PhD, RN   Genotyping Cardiac Patients May Reduce Risks From DAPT -STEMI patient study reaches noninferiority mark for adverse cardiac events by Vicki Brower, CME Writer, MedPage Today September 7, 2019 In the investigational arm, all 1,242 patients were tested […]

Read Full Post »

Co-Curation Articles on MedTech and Cardiovascular Medical Devices by LPBI Group’s Team Members and Aviva Lev-Ari, PhD, RN On 8/13/2018 Co-Curations by LPBI Team Members and Aviva Lev-Ari, PhD, RN N = 51 67co  ATP – the universal energy carrier in the living cell: Reflections on the discoveries and applications in Medicine Curators: Larry H. Bernstein, MD, FCAP […]

Read Full Post »

Moderate Ischemic Mitral Regurgitation: Outcomes of Surgical Treatment during CABG vs CABG without Mitral Valve Repair Curator: Aviva Lev-Ari, PhD, RN   Original Article Michler RE et al. Two-year outcomes of surgical treatment of moderate ischemic mitral regurgitation. N Engl J Med2016 Apr 3; [e-pub]. (http://dx.doi.org/10.1056/NEJMoa1602003) – See more at: http://www.jwatch.org/na40963/2016/04/03/repairing-moderate-mitral-regurgitation-during-cabg-update#sthash.3wfUSvPm.dpuf   April 3, 2016 Repairing Moderate Mitral Regurgitation […]

Read Full Post »

Next »